Dr. Uchio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 The City Dr S
Orange, CA 92868Phone+1 714-456-7005Fax+1 714-456-5342
Education & Training
- National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2001 - 2002
- University of WashingtonResidency, Urology, 1995 - 2001
- University of California, Irvine, School of MedicineClass of 1995
- University of California, IrvineB.S., 1991
Certifications & Licensure
- CA State Medical License 2011 - 2025
- WA State Medical License 1995 - 2017
- CT State Medical License 2003 - 2012
- MD State Medical License 2002 - 2003
- American Board of Urology Urology
Awards, Honors, & Recognition
- Top Urologist CA The Leading Physicians of The World, 2013
- Top Urologist CT The Leading Physicians of The World, 2012
- Fellow American College of Surgeons, 2007
- Join now to see all
Clinical Trials
- Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma Start of enrollment: 2006 Jun 01
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
- LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve Start of enrollment: 2021 Apr 22
Roles: Contact
Publications & Presentations
PubMed
- 131 citationsDevelopment and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancerDaniel E. Spratt, Jingbin Zhang, Maria Santiago-Jimenez, Robert T. Dess, John W. Davis
Journal of Clinical Oncology. 2017-11-29 - 439 citationsRobot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trialDipen J. Parekh, Isildinha M. Reis, Erik P. Castle, Mark L. Gonzalgo, Michael Woods
Lancet. 2018-06-23 - 319 citationsPembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, ...Thomas Powles, Tibor Csőszi, Mustafa Ozguroglu, Nobuaki Matsubara, Lajos Géczi
The Lancet. Oncology. 2021-07-01
Journal Articles
- Effects of androgen deprivation on cerebral morphometry in prostate cancer patients – an exploratory studyChoa HH, Hu S, Ide JS, Uchio E, Zhang S, Rose M, Concato J, Li CS, PLoS One, 8/1/2013
- Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysisChao HH, Uchio E, Zhang S, Hu S, Bednarski SR, Luo X, Rose M, Concato J, Li CS, BMC Cancer, 8/1/2012
- Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survivalGuo X, Schmitz JC, Kenney BC, Uchio EM, Kulkarni S, Cha CH, Cancer Sci, 8/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- “Molecular Markers and Long-term Prognosis in Prostate Cancer.”Uchio EM, Jain D, Risch H, Li W, Wells CK, Concato J, Annual AUA Meeting, Chicago, IL, 1/1/2009
- “The Clinical Utility of Urine Cytology and Fluorescence in situ Hybridization (FISH) for Detecting Transitional Cell Carcinoma (TCC) in a Veterans Population.”Uchio EM, Calderon J, Neto A, Taylor J, Hwang J, Concato J, Annual AUA Meeting, Chicago, IL, 1/1/2009
- “The Role of Met Receptor Expression in Prostate Cancer.”Uchio EM, Cha C, Calderon J, Hwang J, Walker J, Sener A, Pautler, S, Annual AUA Meeting, Chicago, IL, 1/1/2009
- Join now to see all
Lectures
- “XTANDI (enzalutamide) capsules: Inhibiting the Androgen Receptor Signaling Pathway at Multiple Steps”Monterey, CA - 1/1/2013
- “New Prostate Screening Guidelines and Advances in Treatment of Prostate Cancer Utilizing Cyberknife Stereotactic Radiation”Riverside Community Hospital, Riverside, CA - 1/1/2013
- “The Evolving Role of the Urologist in Oncology"Orange, CA - 1/1/2013
- Join now to see all
Press Mentions
- YOUR HEALTH: A Simpler Incision, a Targeted “Zap”, and a Faster Recovery for Prostate Cancer PatientsAugust 9th, 2019
- New Ultrasound Technology Targets Prostate CancerFebruary 15th, 2019
- EDAP TMS SA : UCI Health Medical Center Becomes First in the U.S. To Treat Patients Using EDAP's Breakthrough Focal One® HIFU TechnologyFebruary 5th, 2019
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: